Cibus, Inc. (CBUS)
1.61
-0.02
(-1.23%)
USD |
NASDAQ |
Sep 18, 16:00
1.60
-0.01
(-0.62%)
After-Hours: 20:00
Cibus Total Liabilities (Quarterly) : 298.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 298.64M |
| March 31, 2026 | 288.72M |
| December 31, 2025 | 283.22M |
| September 30, 2025 | 278.20M |
| June 30, 2025 | 271.72M |
| March 31, 2025 | 261.09M |
| December 31, 2024 | 252.24M |
| September 30, 2024 | 246.99M |
| June 30, 2024 | 246.31M |
| March 31, 2024 | 213.21M |
| December 31, 2023 | 206.12M |
| September 30, 2023 | 203.74M |
| June 30, 2023 | 193.09M |
| March 31, 2023 | 17.62M |
| December 31, 2022 | 15.19M |
| September 30, 2022 | 17.86M |
| June 30, 2022 | 18.26M |
| March 31, 2022 | 23.42M |
| December 31, 2021 | 23.06M |
| September 30, 2021 | 23.70M |
| Date | Value |
|---|---|
| June 30, 2021 | 25.88M |
| March 31, 2021 | 26.82M |
| December 31, 2020 | 26.45M |
| September 30, 2020 | 27.58M |
| June 30, 2020 | 24.41M |
| March 31, 2020 | 23.88M |
| December 31, 2019 | 25.59M |
| September 30, 2019 | 24.28M |
| June 30, 2019 | 23.39M |
| March 31, 2019 | 22.97M |
| December 31, 2018 | 25.39M |
| September 30, 2018 | 24.39M |
| June 30, 2018 | 22.60M |
| March 31, 2018 | 18.01M |
| December 31, 2017 | 14.69M |
| September 30, 2017 | 13.46M |
| June 30, 2017 | 9.353M |
| March 31, 2017 | 4.671M |
| December 31, 2016 | 3.504M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AIxCrypto Holdings, Inc. | 1.721M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| TruBridge, Inc. | 228.85M |
| NovelStem International Corp. | 2.097M |
| Veradigm, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 313.45M |
| Shareholders Equity (Quarterly) | 14.80M |
| Debt to Equity Ratio | 19.34 |
| Current Ratio | 1.624 |
| Net Debt Paydown Yield | -8.18% |